Wilmington Savings Fund Society, FSB
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 900974
WILMINGTON, DE
Position in REGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$66,095
-$15,804 QoQ
Shares Held
106
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,106
of 1,322 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $11,168,948 across 32 Biotechnology names. REGN ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
108,446 | $6,080,566 | |
| 2 | ABSI |
Absci Corp
|
189,522 | $2,196,559 | |
| 3 | TECH |
BIO-TECHNE Corp
|
28,159 | $1,989,433 | |
| 4 | ARGX |
Argenx SE
|
239 | $221,736 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
370 | $183,789 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
393 | $146,066 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
106 | $66,095 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
1,633 | $60,763 |
All Filings in REGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,095 | 106 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $81,899 | 106 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $81,818 | 106 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $59,600 | 106 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $381,150 | 726 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $780,736 | 1,231 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,207,398 | 1,695 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $1,902,744 | 1,810 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $648,485 | 617 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $603,481 | 627 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $522,579 | 635 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $474,954 | 661 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $543,123 | 661 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $470,411 | 652 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $449,143 | 652 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $385,416 | 652 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $455,369 | 652 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $411,751 | 652 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $394,577 | 652 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $364,168 | 652 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $310,379 | 656 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $513,545 | 1,063 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||